tiprankstipranks
Trending News
More News >
InMed Pharmaceuticals (INM)
NASDAQ:INM
US Market
Advertisement

InMed Pharmaceuticals (INM) Income Statement

Compare
379 Followers

InMed Pharmaceuticals Income Statement

Last quarter (Q4 2025), InMed Pharmaceuticals's total revenue was $4.94B, an increase of 281278.73% from the same quarter last year. In Q4, InMed Pharmaceuticals's net income was $6.37M. See InMed Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 4.94B$ 6.29M$ 5.48M$ 1.40M$ 0.00
Gross Profit
$ 1.71B$ 1.51M$ 1.86M$ 699.85K$ -197.03K
Operating Expenses
$ 9.41B$ 12.63M$ 12.96M$ 18.46M$ 9.94M
Depreciation and Amortization
$ 212.84M$ 826.76K$ 789.55K$ 658.96K$ 197.03K
EBITDA
$ -7.49B$ -10.30M$ -10.31M$ -17.10M$ -9.80M
Operating Income
$ -7.71B$ -11.12M$ -11.10M$ -17.76M$ -9.92M
Other Income/Expenses
$ -456.98M$ 637.29K$ 588.54K$ -6.19M$ 2.12M
Pretax Income
$ -8.16B$ -10.49M$ -10.51M$ -23.95M$ -10.20M
Net Income
$ -8.16B$ -10.50M$ -10.53M$ -23.95M$ -10.20M
Per Share Metrics
Basic EPS
$ -8.36$ -10.07$ -43.00$ -426.90$ -470.60
Diluted EPS
$ -8.36$ -10.07$ -43.10$ -427.00$ -470.60
Weighted Average Shares Outstanding
975.99K----
Weighted Average Shares Outstanding (Diluted)
975.99K----
Currency in USD

InMed Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis